- Flutamide administration is as a 250 mg oral capsule given every 8 hours.

- For stage B2-C prostatic carcinoma, patients should take flutamide in combination with a gonadotropin-releasing hormone analog that is started eight weeks before the initiation of radiation therapy and continued throughout the course of radiation treatment.

- Patients should take flutamide for stage D2 metastatic carcinoma of the prostate in combination with a gonadotropin-releasing hormone analog.